100 related articles for article (PubMed ID: 29273278)
1. Co-expression of PDGF-B and VEGFR-3 strongly correlates with poor prognosis in hepatocellular carcinoma patients after hepatectomy.
Chen B; Liu J; Wang X; Shen Q; Li C; Dai C
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):126-133. PubMed ID: 29273278
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
[TBL] [Abstract][Full Text] [Related]
4. High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma.
Zhang Y; Zha TZ; Hu BS; Jiang C; Ge ZJ; Zhang K; Tan YF
Surgeon; 2013 Apr; 11(2):67-71. PubMed ID: 22878099
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
Ann Oncol; 2010 Feb; 21(2):223-231. PubMed ID: 19628565
[TBL] [Abstract][Full Text] [Related]
6. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
[TBL] [Abstract][Full Text] [Related]
7. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.
Liu W; Wang N; Lu M; Du XJ; Xing BC
Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121
[TBL] [Abstract][Full Text] [Related]
8. Expression of platelet-activating factor receptor: a novel prognosticator in patients with hepatocellular carcinoma following hepatectomy.
Kitagawa D; Taketomi A; Kayashima H; Kuroda Y; Itoh S; Yamashita Y; Maehara Y
Oncology; 2007; 72(5-6):381-7. PubMed ID: 18187960
[TBL] [Abstract][Full Text] [Related]
9. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
10. VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy Dynamic Contrast Enhanced CT.
Thaiss WM; Kaufmann S; Kloth C; Nikolaou K; Bösmüller H; Horger M
Eur J Radiol; 2016 Nov; 85(11):2036-2041. PubMed ID: 27776657
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome.
Xiang Z; Zeng Z; Tang Z; Fan J; Sun H; Wu W; Tan Y
Cancer J; 2009; 15(6):519-25. PubMed ID: 20010172
[TBL] [Abstract][Full Text] [Related]
12. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
13. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
14. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of receptor for advanced glycation end products expression in hepatocellular carcinoma after hepatectomy.
Ito R; Ishii Y; Wakiyama S; Shiba H; Fujioka S; Misawa T; Ishida Y; Hano H; Yanaga K
J Surg Res; 2014 Dec; 192(2):503-8. PubMed ID: 25043528
[TBL] [Abstract][Full Text] [Related]
16. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma.
Chu JS; Ge FJ; Zhang B; Wang Y; Silvestris N; Liu LJ; Zhao CH; Lin L; Brunetti AE; Fu YL; Wang J; Paradiso A; Xu JM
J Exp Clin Cancer Res; 2013 Apr; 32(1):16. PubMed ID: 23552472
[TBL] [Abstract][Full Text] [Related]
19. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
[TBL] [Abstract][Full Text] [Related]
20. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]